Cystic fibrosis year in review 2018, part 2.

Published in: Pediatric pulmonology (2019)

Cystic fibrosis (CF) research and case reports were robust in the year 2018. This report summarizes publications related the multisystem effects of CF, pulmonary exacerbations, new and expanded therapies other than cystic fibrosis transmembrane conductance regulator modulator studies, and patient-reported priorities and outcomes.

Keyphrases

cystic fibrosis
patient reported
pseudomonas aeruginosa
lung function
pulmonary hypertension
chronic obstructive pulmonary disease
metabolic syndrome
glycemic control